Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine

Biological Psychiatry

Volumn 43, Issue 6, 1998, Pages 436-445

  Bakshi, Vaishali P ^a   Swerdlow, Neal R ^b   Braff, David L ^b   Geyer, Mark A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antipsychotic; Prepulse inhibition; Rat; Schizophrenia; Sensorimotor gating; Startle

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; SOCIAL ISOLATION; STARTLE REACTION;

EID: 17344395207     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00246-1     Document Type: Article

References (47)

1. Bakshi VP, Geyer MA (1995): Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology 122: 198-201.
2. Bakshi VP, Swerdlow NR, Geyer MA (1994): Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794.
3. Bakshi VP, Schwarzkopf SB, Braff DL, Geyer MA (1996): Long-term behavioral and neurochemical changes after isolation rearing in rats. Soc Biol Psychiatry Abst 39:555.
4. Beasely CM, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S, Olanzapine HGAD Study Group (1995): Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 14:111-123.
5. Bolino F, Di Michele V, Di Cicco L, Manna V, Daneluzzo E, Cassachia M (1994): Sensorimotor gating and habituation evoked by electrocutaneous stimulation in schizophrenia. Biol Psychiatry 36:670-679.
6. Borison RL, Arvanitis LA, Miller BG (1996): ICI 204,636, an atypical antipsychotic: Efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group. J Clin Psychopharmacol 16:158-169.
7. Braff DL, Geyer MA (1990): Sensorimotor gating and schizophrenia: Human and animal model studies. Arch Gen Psychiatry 47:181-188.
8. Braff DL, Stone C, Callaway E, Geyer MA, Glick ID, Bali L (1978): Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343.
9. Braff DL, Grillon C, Geyer MA (1992): Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206-215.
10. Bristow LJ, Landon L, Saywell KL, Tricklebank MD (1995): The glycine/NMDA receptor antagonist, L-701,324, reverses isolation-induced deficits in prepulse inhibition in the rat. Psychopharmacology 118:230-232.
11. Cadenhead KS, Geyer MA, Braff DL (1993): Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry 150:1862-1867.
12. Coward DM (1992): General pharmacology of clozapine. Br J Psychiatry 160(suppl 17):5-11.
13. Crespi F, Wright IK, Mobius C (1992): Isolation rearing of rats alters release of 5-hydroxytryptamine and dopamine in the frontal cortex: An in vivo electrochemical study. Exp Brain Res 88:495-501.
14. Fabre LF (1993): A multicenter, open, pilot trial of ICI 204,636 in hospitalized patients with acute psychotic symptomatology. Proc Int Cong Schizophr Res.
15. Geyer MA, Markou A (1995): Animal models of psychiatric disorders. In: Bloom FE, Kupfer DJ (eds), Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp 787-798.
16. Geyer MA, Swerdlow NR, Mansbach RS, Braff DL (1990): Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25:485-498.
17. Geyer MA, Wilkinson LS, Humby T, Robbins TW (1993): Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol Psychiatry 34:361-372.
18. Grillon C, Ameli R, Charney DS, Krystal J, Braff DL (1992): Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry 32:939-943.
19. Hamm A, Weike A, Bauer U, Vaitl D, Gallhofer B (1995): Prepulse inhibition in medicated and unmedicated schizophrenics. Psychophysiology 32(suppl 1):S65.
20. Hoffman HS, Ison JR (1980): Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev 87:175-189.
21. Ison JR, Hoffman HS (1983): Reflex modification in the domain of startle: II. The anomalous history of a robust and ubiquitous phenomenon. Psychol Bull 94:3-17.
22. Jones GH, Marsden CA, Robbins TW (1990): Increased sensitivity to amphetamine and reward-related stimuli following social isolation in rats: Possible disruption of dopamine-dependent mechanisms of the nucleus accumbens. Psychopharmacology 102:364-372.
23. Jones GH, Hernandez TD, Kendall DA, Marsden CA, Robbins TW (1992): Dopaminergic and serotonergic function following isolation rearing in rats: Study of behavioural responses and postmortem and in vivo neurochemistry. Pharmacol Biochem Behav 43:17-35.
24. Kodsi MH, Swerdlow NR (1994): Quinolinic acid lesions of the ventral striatum reduce sensorimotor gating of acoustic startle in rats. Brain Res 643:59-65.
25. Mansbach RS, Geyer MA, Braff DL (1988): Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507-514.
26. McGhie A, Chapman J (1961): Disorders of attention and perception in early schizophrenia. Br J Med Psychol 34:103-116.
27. Migler BM, Warawa EJ, Malick JB (1993): Seroquel: Behavioral effects in conventional and novel tests for atypical antipsychotic drugs. Psychopharmacology 112:229-307.
28. Moore NA, Tye NC, Axton MS, Risius FC (1992): The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J Pharmacol Exp Ther 262:545-551.
29. Moore NA, Calligaro DO, Wong DT, Bymaster F, Tye NC (1993): The pharmacology of olanzapine and other new antipsychotic agents. Curr Opin Invest Drugs 2:281-293.
30. Nuechterlein KH, Dawson ME (1985): Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull 10:160-203.
31. Rasmussen K, Gates MR, Burger JE, Czachura JF (in press): The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibition. Neurosci Lett.
32. Saller CF, Salama AI (1993): Seroquel: Biochemical profile of a potential atypical antipsychotic. Psychopharmacology 112: 285-292.
33. Sipes TA, Geyer MA (1994): Multiple serotonin receptor sub-types modulate prepulse inhibition of the startle response in rats. Neuropsychopharmacology 33:441-448.
34. Swerdlow NR, Geyer MA (1993a): Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav 44:741-744.
35. Swerdlow NR, Geyer MA (1993b): Prepulse inhibition of acoustic startle in rats after lesions of the pedunculopontine tegmental nucleus. Behav Neurosci 107:104-117.
36. Swerdlow NR, Braff DL, Masten VL, Geyer MA (1990): Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology 101:414-420.
37. Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991): Effects of spiperone, raclopride, SCH23390 and clozapine on apomorphine-inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 256:530-536.
38. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994a): Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51: 139-154.
39. Swerdlow NR, Zisook D, Taaid N (1994b): Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: Similarities to clozapine. Psychopharmacology 114:675-678.
40. Swerdlow NR, Bakshi VP, Geyer MA (1996): Seroquel restores sensorimotor gating in phencyclidine (PCP)-treated rats. J Pharmacol Exp Ther 279:1290-1299.
41. Varty GB, Higgins GA (1995): Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology 122:15-26.
42. Weike A, Globisch J, Hamm A, Bauer U (1996): Prepulse inhibition and habituation of skin conductance responses in schizophrenics: Neuroleptic drug effects. Psychophysiology 33(suppl 1):S88.
43. Weinberger DR (1987): Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669.
44. Wetzel H, Szegedi A, Hain C, Wiesner J, Schlegel S, Benkert O (1995): Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: Results of an open clinical trial and changes of neuroendocrinological and EEG parameters. Psychopharmacology 119: 231-238.
45. Wilkinson LS, Killcross SS, Humby T, Hall FS, Geyer MA, Robbins TW (1994): Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition. Neuropsychopharmacology 10:61-72.
46. Wright IK, Ismail H, Upton N, Marsden CA (1991): Effect of isolation rearing on 5-HT agonist-induced responses in the rat. Psychopharmacology 105:259-263.
47. Wu JC, Potkin SG, Ploszaj DI, et al (1992): Clozapine improves sensory gating more than haldol. APA Abstr., 145th Annual Meeting, p. 156.